Stämm Biotech
Carlos German Carreño Romano has a diverse work experience spanning various industries and roles. Carlos German is currently employed at Stämm Biotech as an Optics Design Engineer and department leader. Prior to this, they worked at Huawei as a Technical Expert in Data Analytics from January 2020 to June 2021.
Carlos also has experience working as a Tesista at Universidad de Buenos Aires from January 2019 to March 2020. Carlos German gained valuable skills and knowledge in research, development, and innovation during their time at Telecom Argentina, where they were involved in the study and definition of technology and architecture of networks and services from January 2018 to September 2019.
Before that, Carlos worked at Cablevisión - Fibertel as a Data Architecture Specialist, focusing on data analysis, traffic engineering, application development, and mathematical modeling using techniques of big data and data mining from June 2015 to January 2018. Carlos German also has experience in planning, strategy, and finance, having worked at LIGHTBODIES, an innovative venture that combines art and technology, from January 2015 to November 2017.
Carlos's earlier work experience includes roles such as Service Management at DLA, Inc. from November 2014 to April 2015, and as a Student Researcher at Grupos de Láser, Óptica de Materiales y Aplicaciones Electromagnéticas (GLOmAE) from February 2014 to December 2014. Carlos German also worked as a NOC Operator at CrossFone Argentina from January 2009 to February 2012.
Overall, Carlos German Carreño Romano has a strong background in optics design, data analytics, research, and development, with experience in various industries and diverse roles.
Carlos German Carreño Romano completed a degree in Electronic Engineering at the University of Buenos Aires, where they studied from an unknown start year until 2020. Prior to that, they pursued a degree in Ingeniería Electrónica at FI UBA from 2008 to 2019.
This person is not in any offices
Stämm Biotech
Stämm is a biotechnology company dedicated to making biomanufacturing easy, scalable, and repeatable. We have developed the first methodology for continuous industrial production of biologics and cell therapies leveraging microfluidics and 3D printing. In 2020, the total volume of anthropogenic mass matched the total amount of biomass globally, which means it matched everything that is alive on the planet. We can only expect that this number keeps increasing since it's key to solving humanity's systemic challenges. But we have to make sure that conquering the great challenges of humanity doesn’t extinguish the planet’s capacity to sustain life. The current way of biomanufacturing has provided humanity with innumerable solutions. Bioprocessing is the most efficient way to align human advancement with a thriving nature. In order to prevent nature from perishing, we aim to put it at the center of all human activities by incorporating its knowledge system within the process of achieving humanity's prosperity. Founded in 2016, Stämm mimics nature’s use of laminar flow to down-size a whole biotech facility into an all-in-one, plug & play desktop unit. Our focus is to decentralize bioprocesses and democratize access to biotechnology products, thus freeing our partners to focus on the disruptive discoveries that make an impact on people’s life.